Kyowa Kirin Co.,Ltd. (4151) Other
Market cap
¥1.26T
P/E ratio
16.7x
Kyowa Kirin manufactures and sells prescription pharmaceuticals through integrated operations from drug development to sales, serving healthcare markets globally.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | 4.1 | 2.6 | 7 | 8.5 | 8.8 | 5.9 | 6.1 | 5.8 | 8.3 | 5.7 | 6.2 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 7,229 | 7,243 | 7,152 | 7,424 | 7,435 | 7,465 | 7,532 | 7,242 | 5,267 | 5,423 | 5,752 | 5,982 | 5,974 | 5,669 | 5,161 |
| Total payout ratio | - | - | - | 86.8 | 46.7 | 73.3 | - | 29.7 | 66 | 50.3 | 46.2 | 47.2 | 35.8 | 118.4 | 46.1 |